Sign in
Retinal Vascular Disease Symposium
Annual Meeting Talks
2020
An analysis of the phase 2 trial with intraviteal aflibercept and suprachoroidal
Michael A. Singer, MD
Updates from the Field
2017
Impact of Baseline OCT Characteristics on Response to Risuteganib for the Treatment of Intermediate Age-Related Macular Degeneration
Justis P. Ehlers, MD, FASRS
Category: Retinal Vascular Disease